Treatment of High-Output Heart Failure
The primary treatment of high-output heart failure is identifying and treating the underlying cause of the elevated cardiac output, NOT standard guideline-directed medical therapy for heart failure with reduced ejection fraction. 1, 2
Critical Distinction from Standard Heart Failure
High-output heart failure is fundamentally different from typical heart failure—the heart is NOT the primary problem. Standard vasodilator therapies (ACE inhibitors, ARBs, beta-blockers) can be dangerous because they further reduce systemic vascular resistance, which is already pathologically low 3, 4. This is the opposite of what these patients need.
Treatment Algorithm
Step 1: Identify and Treat the Underlying Cause
The most common etiologies requiring specific interventions include 1, 2, 4:
- Anemia (36% of cases): Correct with transfusion or treat underlying cause
- Thyrotoxicosis: Antithyroid medications or radioablation
- Arteriovenous shunts/fistulas: Surgical ligation or reduction of flow 5, 6
- Cirrhosis/liver failure (17% of cases): Treat portal hypertension, consider transplant evaluation
- Sepsis: Antimicrobial therapy and source control
- Obesity (34% of cases): Weight reduction
- Paget's disease: Bisphosphonates
- Beriberi (thiamine deficiency): Thiamine replacement
Surgical intervention for arteriovenous fistulas can normalize cardiac function within 6 months 5, 6.
Step 2: Symptomatic Management of Volume Overload
Diuretics are essential when fluid overload is present (pulmonary congestion, peripheral edema), as these patients do develop volume retention despite high cardiac output 7:
- Loop diuretics (furosemide 20-240 mg daily, bumetanide 1-5 mg daily, or torasemide 10-20 mg daily) 8
- Titrate to achieve euvolemia ("dry weight")
- Avoid excessive diuresis which can reduce preload and worsen cardiac output 7
- Monitor renal function and electrolytes closely
Step 3: Rate Control if Tachycardia Present
If atrial fibrillation or persistent tachycardia contributes to symptoms:
- Digoxin for rate control in atrial fibrillation 7
- Beta-blockers may be used cautiously for rate control, but avoid if they worsen hypotension 9
- Target heart rate 70-100 bpm to allow adequate diastolic filling
Step 4: Cautious Use of Standard HF Medications
ACE inhibitors and other vasodilators should be used with extreme caution or avoided entirely 3:
- If the underlying cause cannot be corrected AND ventricular dysfunction develops, consider low-dose ACE inhibitors
- Start with very low doses (e.g., captopril 6.25 mg sublingual TID if oral route unavailable) 6
- Monitor blood pressure closely—hypotension indicates excessive vasodilation
- Never use standard GDMT dosing protocols designed for HFrEF
Common Pitfalls to Avoid
Reflexively starting standard HF medications: This is the most dangerous error. High-output HF mimics HFrEF clinically but requires opposite management 1, 3
Missing the diagnosis: Requires right heart catheterization showing cardiac index >4 L/min/m² with low systemic vascular resistance 4
Aggressive diuresis: While diuretics are needed, excessive use reduces preload in an already high-flow state 7
Ignoring treatable causes: Many etiologies (anemia, thyroid disease, AV fistulas) are completely reversible 2, 5
Prognosis and Monitoring
High-output heart failure carries significant mortality (25-39% at median follow-up of 17-31 months) 4. Close monitoring is essential:
- Serial echocardiography to assess ventricular function
- Repeat right heart catheterization if considering interventions
- Monitor for development of pulmonary hypertension 5
- Assess response to treatment of underlying cause
The key to successful management is recognizing that this is NOT typical heart failure—the treatment paradigm must focus on the underlying high-output state, not the heart itself 1, 3.